Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PCN172 TREATMENT PATTERNS AMONG PATIENTS WITH ADVANCED BREAST CANCER PREVIOUSLY TREATED WITH AN ANTHRACYCLINE AND A TAXANE: A RETROSPECTIVE LONGITUDINAL STUDY

Autor: Colman, S, Strizek, A, O'Leary, BA, Ruth, AJ, Cook, GA

Publikováno v: In Value in Health 2009 12(7):A290-A290

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

OX40 ligand is inhibitory during the effector phase of crescentic glomerulonephritis.

Autor: Odobasic D; Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, Clayton, Victoria, Australia., Ruth AJ; Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, Clayton, Victoria, Australia., Oudin V; Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, Clayton, Victoria, Australia., Kitching AR; Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, Clayton, Victoria, Australia.; Department of Pediatric Nephrology, Monash Health, Clayton, Victoria, Australia.; Department of Nephrology, Monash Health, Clayton, Victoria, Australia., Holdsworth SR; Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, Clayton, Victoria, Australia.; Department of Nephrology, Monash Health, Clayton, Victoria, Australia.

Publikováno v: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2019 Mar 01; Vol. 34 (3), pp. 429-441.